Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-blind, Positive-controlled Phase Ⅲ Clinical Trial of Bicyclol Tablets in the Treatment of Acute Drug-induced Liver Injury

NCT05063500 is registered in ClinicalTrials.gov with Drug Induced Liver Disease Study Group as lead sponsor.

NCT NCT05063500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05063500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-blind, Positive-controlled Phase Ⅲ Clinical Trial of Bicyclol Tablets in the Treatment of Acute Drug-induced Liver Injury
Lead sponsor
Drug Induced Liver Disease Study Group
Phase
Phase 3
Overall status
Unknown status
Start date
December 20, 2021
Completion date
June 30, 2023
Enrollment
360 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

drug-induced acute liver injury